Objective: Whey-based formulas have faster gastric emptying than casein-based formulas. Isoenergetic, isovolumic, whey-based formulas of different osmolarity and fat content empty in a similar manner. Will the gastric emptying of high and low energy density whey-based formulas be similar? Design: We studied the gastric emptying rate of equal volumes of two whey-based formulas of different energy density (4.18 kJ=ml and 6.27 kJ=ml) and osmolality (270 and 450 mOsm=kg, respectively) in 10 children (4.5 -12 y) with volume intolerance and resultant inability to gain weight. Results: The two formulas had comparable gastric emptying rates at 30, 60, 90 and 120 min. Over a one month clinical trial, substitution of the lower energy density whey-based formula (no weight gain over 2 months) with an equal volume of the high energy density formula produced a mean weight gain of 1.17 AE 0.5 kg per patient without change in tolerance. Conclusion: The higher density whey-based formula can safely substitute an equal volume of a lower energy density formula to produce weight gain without affecting tolerance. Implication: This provides an important intervention for increasing energy intake in children with volume intolerance or fluid restriction.
Introduction
Gastric emptying of liquids is influenced by several factors, particularly type and content of fat, volume and osmolarity. The most important factor, which governs gastric emptying, is the energy content of the meal and it overrides the energy composition of the meal (Hunt et al, 1985; Hunt & Stubbs, 1975) . Earlier, we have shown that the type of protein is also an important factor that affects gastric emptying of liquid formulas (Fried et al, 1992) . Different types of isoenergetic, isovolumic whey-based formulas empty faster than similar casein-based formulas and are associated with fewer episodes of emesis and gastroesophageal reflux (Fried et al, 1992; Khoshoo et al, 1996; Billeaud et al, 1990; Tolia et al, 1992) . This effect is seen irrespective of the osmolarity, fat composition or nature of whey. The next logical step is to evaluate whether the presence of whey as the protein moiety will override the energy content of the meal in influencing gastric emptying of a liquid formula. We studied the gastric emptying rates of equal volumes of two similar whey-based formulas of different energy densities, ie 4.18 and 6.27 kJ=ml, in children with volume intolerance and also assessed weight gain.
Methods
This study was conducted in a prospective manner after approval from the Institutional Review Board. The study population comprised of 10 children with spastic quadri-plegia (4.5 -12 y; six male, four female) who were fed exclusively through a gastrostomy tube using bolus feeds. All children were referred to the Pediatric Gastroenterology and Nutrition Clinic more than 6 months prior to the study for poor weight gain secondary to volume intolerance as manifested by gagging, discomfort or emesis following bolus feeds. To hasten gastric emptying and improve tolerance the formula had already been switched to a whey-based formula; however, the children were still unable to advance the volume to optimize energy intake for weight gain. For this reason all patients had failed to gain any weight during the previous 2 months. They were all managed by the same physician, on an intent-to-treat basis. After obtaining written consent and overnight fast a Tc99 sulfur colloid gastric emptying scan was performed with 150 ml of either of the two formulas in random allocation as described before (Fried et al, 1992) . After at least 48 h, to allow time for decay of radioactivity, a similar scan was repeated with the other formula. All conditions were kept identical during both scans including timing of the scans. Each scan was performed for 120 min. The radiologist performing and interpreting the scans was unaware of the formula used. The formulas used were: Peptamen (4.18 kJ=ml, 270 mOsmol=kg) and Peptamen 1.5 (6.27 kJ=ml, 450 mOsmol=kg). These formulas were selected because despite different energy densities they have a similar energy composition and both formulas are commercially available (Nestle Clinical Nutrition Inc., Deerfield, IL, USA), hence have immediate patient care relevance. The composition of these formulas is provided in Table 1 . Following the second scan the formula was switched to Peptamen 1.5 but delivered in the exact same manner as Peptamen, ie same volume, duration of infusion and feeding schedule. The parents were asked to maintain a diary of symptoms suggesting intolerance, ie gagging, discomfort, emesis and diarrhea. A 1 month trial of this higher energy formula was given during which time nude body weights were monitored on a weekly basis. Following this period the nutritional intervention was reassessed and appropriate changes were made with a view to optimizing nutritional status. Data on individual patients and groups was compared using a paired t-test and two-way ANOVA for repeated measures.
Results
All patients were clinically stable with normal hydration status (urine specific gravity < 1.025), normal thyroid functions (thyroxine, thyroid stimulating hormone), serum albumin and electrolytes (Na, K, Cl, Mg, Ca and CO 2 ). Each patient served as his=her own control. The gastric emptying of the two formulas, at all phases of the 120 min study period was similar in all patients individually (P > 0.05). The mean AE s.d. percentage residual gastric activity of the two formulas at 30, 60, 90 and 120 min was similar (P > 0.05) and is given in Table 2 . Eight of these 10 patients were enrolled for the clinical trial with Peptamen 1.5. Two patients were excluded because they were considered unreliable. Patients were considered unreliable if they had a history of having missed more than two clinic appointments over the past 1 y without sufficient reason. This was important to predetermine because we felt that the semi-objective data on tolerance recorded by the parents over the course of the 1 month trial with Peptamen 1.5 needed to be recorded conscientiously and in an extremely reliable manner. The mean weight gain over the 1 month trial period with equal volume of Peptamen 1.5 (1.17 AE 0.5 kg) was significantly greater than (P < 0.05) the no weight gain observed over the previous 2 months while consuming Peptamen. The parents reported no change in general symptoms, symptoms of tolerance or stooling pattern during the trial with Peptamen 1.5 as compared to while the children were consuming an equal volume and identical feeding schedule with Peptamen.
Discussion
Gastric emptying of liquid formulas is affected by several factors. Increased osmolarity and a higher fat content delay gastric emptying. The energy content of a meal, irrespective of its composition, has been shown to be the most important factor that affects the gastric emptying of a meal (Hunt et al, 1985; Hunt & Stubbs, 1975) . We have shown that the nature of protein is another factor that influences the gastric emptying of a liquid meal, irrespective of osmolarity and energy composition, ie whey-based formulas empty the stomach faster than equal volumes of isoenergetic casein-based formulas (Fried et al, 1992) . However, equal volumes and energy content of different whey-based formulas empty the stomach in a comparable manner despite differences in their composition, ie a hyperosmolar, intact whey-based formula; Gastric emptying of two whey-based formulas V Khoshoo and S Brown a hyperosmolar, whey hydrolysate-based formula and an isoosmolar, whey hydrolysate-based formula with fat content predominantly as medium chain triglycerides (Fried et al, 1992) . This clearly implies that the nature of protein, ie whey, overrides the osmolarity and fat content of a formula in affecting its gastric emptying. Therefore whey as well as the energy content of the meal emerge as the two most important determinants of gastric emptying. Data from the present study suggests that the presence of whey as the protein moiety in a liquid formula will override the effects of the energy content of the meal since equal volumes of two similar whey-based formulas of very different energy densities were shown to empty at similar rates despite a major difference in osmolarity and total fat, carbohydrate and protein content. These findings were corroborated during a one-month trial of Peptamen 1.5, the whey-based formula with higher energy density. In accordance with the results of the gastric emptying scans, and as expected, there was no change in tolerance after the formula was changed from Peptamen to an equal volume of Peptamen 1.5 and produced the desired outcome of a significant weight gain.
In conclusion, our present study shows that higher density whey-based formulas could be effectively delivered to produce weight gain without change in tolerance in children receiving lower density whey-based formula and who have reached their maximum tolerated volume and fail to gain further weight. We already know that whey-based formulas empty faster than casein-based formulas. It is then logical to state that a higher density whey-based formula can safely substitute equal volume of lower energy density whey or casein-based formula. This provides the basis of an effective intervention to increase energy intake in patients with volume intolerance or fluid restriction without compromising tolerance.
